Study objectives: To describe the characteristics and outcomes of patients admitted to intermediate-care areas (ICAs) and to compare them with those of ICU patients who receive monitoring only on day 1 and are at a low risk (ie, < 10%) for receiving subsequent active life-supporting therapy (ie, low-risk monitor patients). Design: Nonrandomized, retrospective, cohort study. Setting: Thirteen US teaching hospitals and 19 nonteaching hospitals. Patients: A consecutive sample of 8,971 patients at 37 ICAs and 5,116 low-risk (ie, < 10%) monitor patients at 59 ICUs in 32 US hospitals. Interventions: None.
P
atients who are admitted to intermediate-care areas (ICAs) of a hospital do not require full intensive care but need more services than those provided on a hospital ward. [1] [2] [3] The type and amount of services provided by ICAs, however, varies depending on resource availability, 1, 4, 5 and the philosophy, organization, and funding of different healthcare systems. 2, 6 As a result, there are marked variations in the roles and capabilities of ICAs internationally and even within individual hospitals. In the United Kingdom, where ICU beds are less available than in the United States, 4,7 intermediate or high-dependency units provide care for patients who have experienced acute myocardial infarctions or those who are at risk for or have already developed single-organ failure. 8, 9 The role and capabilities of ICAs in US hospitals also differ. Some are multipurpose areas that act as a step-up or step-down from care delivered on wards and in ICUs, and others provide specialty care for medical, cardiac, surgical, neurologic, respiratory, or chronic ventilator patients. 3 There are several reasons why hospitals have developed ICAs. First, they facilitate earlier hospital discharges of stable ICU patients who are thought to need more care than can be provided on wards. 10 -13 Second, they may decrease the need for ICU readmission by providing more monitoring and nursing care than is available on hospital wards. 14 -16 Third, they appear to decrease patient mortality rates in hospitals that are experiencing marked pressure on the availability of beds in ICUs. [17] [18] [19] Fourth, they may reduce the cost of treating patients who do not need the unique services of an ICU 6,20 -24 by providing care in areas with a lower nurse/patient ratio and less complex technology. 6, [25] [26] [27] Although many US hospitals have developed ICAs, there have been no multicenter descriptions of ICA patients or their outcomes. In addition, patients admitted to the hospital for monitoring who are at a low risk for receiving life support (ie, low-risk monitor patients) 28 -31 often receive care in ICAs rather than in ICUs. [32] [33] [34] [35] There have not been any comparisons of outcomes for these low-risk patients in ICAs vs ICUs. The purpose of this study was to describe the demographic and clinical characteristics of a multihospital population of US ICA patients. We also compared the characteristics, resource use, and outcomes of ICA patients with those of ICU low-risk monitor patients who were being treated at the same hospitals.
Materials and Methods
The patient data and outcomes for this study were collected, concurrently or retrospectively, between May 1993 and September 1998. The hospitals were selected because each had collected data in an ICA. Data for ICU patients were collected in the same hospitals. Twenty-five of the hospitals collected patient data to assess and compare risk-adjusted mortality rates and resource use to national benchmarks, and 10 hospitals were clients of a private company (APACHE Medical Systems; McLean, VA). For each client hospital, the analysis was limited to the data collected during the first 4 to 12 months to ensure that reliability testing had been completed and to minimize any potential bias introduced by the information collected. The average duration of data collection for the other 25 hospitals that conducted benchmark comparisons was 3.1 months. The methods, training, and support provided for data collection have been reported previously. 36 Each hospital provided information about bed size and teaching status as defined by membership in the Council of Teaching Hospitals (COTH), the presence of one or more accredited residency programs (ie, non-COTH teaching hospitals), or neither (nonteaching hospitals). The type of ICA and ICU that was used was reported by each hospital. To eliminate uncertainties in definition, we excluded data from any ICA that cited a nurse/ patient ratio of Ͼ 1:2 31, 37 or provided active life-supporting therapy for Ͼ 20% of hospital admissions. Table 1 lists the active life-supporting therapies used for this study and in previous work by Zimmerman and colleagues. 31 We also excluded ICAs that failed to meet previously published data reliability criteria. 38 Informed consent was not obtained because of the existence of prior institutional review board waivers for identical data collection efforts during previous studies. 36, 38 
Patient Information
The data that were generated as a result of patient care and were recorded in the medical record were collected concurrently or retrospectively for consecutive hospital admissions at each ICA and ICU. For each patient, we recorded age, gender, race, and the comorbidity and physiologic data required to calculate an acute physiology and chronic health evaluation (APACHE) III score. We also recorded whether active life-supporting therapy was received on the unit on day 1, patient location and length of stay in the hospital before admission to the unit, operative status, and whether there was emergency surgery or unit readmission. Definitions of the above variables have been reported else- where. 31, 38 Each patient's primary reason for unit admission (ie, the admission diagnosis) was recorded by selecting 1 of 430 diseases, injuries, surgical procedures, or events that was most immediately threatening to the patient and that required ICA or ICU services. The methods used to record and track unit admission diagnoses have been previously reported. 36 For this study, we excluded patients who had been admitted to the hospital for Ͻ 4 h, patients with burns, patients who were Ͻ 16 years of age, and unit readmissions. We also excluded ICU patients who during day 1 received active life-supporting therapy and ICU patients who received only monitoring services during day 1 but were at a high risk (ie, Ն 10%) for subsequently receiving active therapy. To do this, we used ICU day 1 active therapy data and a previously validated multivariate predictive equation to identify ICU monitor patients who were at a low risk (ie, Ͻ 10%) for receiving subsequent active therapy. 31 We used the same predictive equation to assess the risk of active therapy for ICA patients who did not receive active therapy on day 1. We emphasize that the risk predicted was for receiving subsequent active therapy, not the risk of mortality. The analysis of risk for active therapy excluded patients who had been admitted to the hospital for chest pain to rule out myocardial infarction and after coronary artery bypass surgery because the predictive equation has not been validated for patients with these diagnoses.
Outcomes recorded for each patient included the duration of unit and hospital stay, unit readmission, transfer to another ICA or ICU, and survival at unit and hospital discharge. To eliminate patients for whom the unit length of stay was uncertain, we excluded patients who were discharged to another ICA or ICU from all analyses of length of stay. We also recorded whether active therapy was received after unit day 1 for 3,374 of the ICU low-risk monitor patients (66%) and 4,975 of the ICA patients (55%). The type of active therapy was not recorded, and these data were collected only at the seven hospitals that were clients of a private company (APACHE Medical Systems).
Data Analysis and Statistics
Univariate statistical comparisons of institutional and patient characteristics were performed using a t test with a significance criterion of p Ͻ 0.05 for hospitals and units and p Ͻ 0.001 for patients to avoid the overreporting of small differences as significant. Data on length of stay were analyzed using mean values to describe total resource use, median values to describe typical patterns, and visual examination of frequency distributions to describe typical patterns and information on outliers, as reflected by rightward skewing. 39 
Results

Hospital and Unit Characteristics
We collected data in 40 ICAs and 59 ICUs at 35 hospitals, but we excluded data from 2 ICAs because they did not meet the definition of intermediate care used in our study. We also excluded data from one ICA because of the failure to meet data reliability criteria. This left 37 ICAs and 59 ICUs at 32 hospitals for analysis. Geographically, 12 of the 32 hospitals (38%) were located in the West, 11 (34%) were located in the Midwest, 7 (22%) were located in the Southeast, and 2 (6%) were located in the Northeast. The mean number of hospital beds was 413 (range, 145 to 900 beds). Thirteen hospitals (41%) met our definition of a teaching hospital (COTH, 3; non-COTH, 10), and 19 hospitals (59%) were nonteaching hospitals. Table 2 summarizes the characteristics of the 37 ICAs and 59 ICUs. Of the ICAs, a majority (81%) were mixed medical-surgical, whereas 51% of the ICUs were specialized.
Patients
Data were collected for 8,971 patients who had been admitted consecutively to the 37 ICAs and for 14,697 patients who had been admitted consecutively to the 59 ICUs. We excluded 7,690 ICU patients who received active life-supporting therapy, 1,641 ICU monitor patients who were at high risk (ie, Ն 10%) of receiving active therapy on ICU day 1, and 250 patients with missing active treatment data. The exclusions described above resulted in a nonrandomized observational sample of 8,971 ICA patients and 5,116 ICU low-risk monitor patients. Among the 8,971 ICA admissions, data were collected for 3,996 patients to compare outcomes to national benchmarks and for 4,975 patients by clients of a private company (APACHE Medical Systems). Among the 5,116 ICU low-risk monitor admissions, data were collected for 1,742 patients to compare outcomes to national benchmarks and for 3,374 patients by clients of a private company (APACHE Medical Systems).
The demographic and clinical characteristics of the ICA and ICU low-risk monitor patients are shown in Table 3 . ICA and ICU low-risk monitor patients were similar in regard to gender, race, and frequency of comorbidities. In contrast, ICA patients were significantly (p Ͻ 0.001) older and had been admitted to the ICA more frequently for nonoperative diagnoses compared to ICU low-risk monitor patients. The severity of physiologic abnormality was also significantly lower for ICA patients than for ICU low-risk monitor patients (mean acute physiology scores, 16.7 vs 19.8, respectively; p Ͻ 0.001). Figure  1 shows the distribution of APACHE III scores for ICA and ICU low-risk monitor patients. Table 4 shows the most frequent nonoperative admission diagnoses for ICA and ICU low-risk monitor patients. The 12 nonoperative admission diagnoses in Table 4 accounted for 55.8% of the nonoperative ICA patients and for 68.8% of the nonoperative ICU low-risk monitor patients. Cardiovascular diagnoses (ie, unstable angina, cardiac dysrhythmia, congestive heart failure, and acute myocardial infarction) accounted for 39.1% of those in nonoperative ICA patients and for 39.2% of those in nonoperative ICU low-risk monitor patients. Admissions to the unit for chest pain and to rule out myocardial infarction accounted for 569 of the 4,765 nonoperative ICA patients (7.6%), but the risk for active therapy could not be assessed among ICU or ICA patients. Table 5 shows the most frequent postoperative admission diagnoses among ICA and ICU low-risk monitor patients. The 12 postoperative admission diagnoses accounted for 60.7% of diagnoses in the postoperative ICA patients and for 59% of diagnoses in the postoperative ICU low-risk monitor patients.
Vascular surgery (ie, carotid endarterectomy, femoral-popliteal artery graft, and operations for peripheral vascular ischemia and aortoiliac or aortofemoral obstructions) accounted for 24.4% of the postoperative ICA patients, and for 24.7% of the postoperative ICU low-risk monitor patients.
Resource Use
Resource use for the 8,971 ICA and 5,116 ICU low-risk monitor patients are summarized in Table  6 . The unit length of stay was significantly longer for ICA patients than for ICU low-risk monitor patients (mean, 3.9 vs 2.6 days, respectively; p Ͻ 0.001). Figure 2 displays the distribution of unit length of stay for the two patient groups. The type of unit and the patient's admission diagnosis had a substantial influence on the mean unit length of stay (Tables 3, 4 ). For example, the mean unit length of stay was 4 days for ICA patients vs 2.2 days for ICU low-risk monitor patients who had been admitted to a unit for cardiac dysrhyth- Table 7 . Among 7,579 ICA patients who received only monitoring services on day 1, 6457 (85.3%) were at a low risk (ie, Ͻ 10%) for subsequent active treatment. Among the 4,237 ICA monitor patients who had active therapy information recorded after unit day 1, 3,646 (86%) were at a low risk on day 1 for active therapy, and 95.7% of these patients never received subsequent active treatment. Of the 3,374 ICU low-risk monitor patients who had active therapy information recorded after unit day 1, 94.3% never received subsequent active treatment.
Patient Outcomes
Outcomes for the 8,971 ICA and 5,116 ICU low-risk monitor patients are also shown in Table 6 . Unit readmission and transfer to another ICU were infrequent for ICA and ICU low-risk monitor patients. The mean in-unit death rate was significantly higher among ICA patients (1.1%) compared to ICU low-risk monitor patients (0.6%; p Ͻ 0.004). The mean hospital mortality rate was also significantly higher for ICA patients (3.1%) compared to ICU low-risk monitor patients (2.3%; p Ͻ 0.003).
Discussion
This study of 8,971 patients who were admitted to 37 ICAs at 32 US hospitals is unique because previous descriptions [22] [23] [24] [25] [26] [27] [32] [33] [34] [35] have been limited to individual units or hospitals. ICA patients had a mean age of 64 years and low severity of illness, with cardiovascular diagnoses accounted for 47% of nonoperative ICA admissions and vascular surgery accounting for 24% of postoperative ICA admissions. We compared the characteristics and outcomes of these ICA patients to those of 5,116 ICU monitor patients who received only monitoring and concentrated nursing care during their first ICU day and were at a low risk (ie, Ͻ 10%) for receiving subsequent active life-supporting therapy. 29, 31 We performed this comparison because we 29 -31,37 and others 11,40 -44 have suggested previously that physicians could identify ICU low-risk monitor patients and treat them safely and effectively in an ICA.
When compared to ICA patients, the ICU low-risk monitor patients were similar in regard to gender, race, comorbidities, and the most frequent admission diagnoses. The ICA patients were, on average, 4 years older and had fewer physiologic abnormalities (mean APACHE III score, 16.7 vs 19.8, respectively) than did ICU low-risk monitor patients. A higher proportion of ICA patients were nonoperative patients, a finding that is probably related to the comparison of patients who were admitted to telemetry and medical-surgical ICAs (97.3%) vs a sample of patients in which 51% of the ICUs to which they were admitted were specialized. The vast majority of ICA patients (91.7%) received only monitoring and concentrated nursing care on day 1, and 85.3% of these patients were at a low risk (ie, Ͻ 10%) for receiving subsequent active therapy. Because 95.7% of these patients never received subsequent active therapy, our results suggest that the method used to assess the risk for active therapy among ICU monitor patients is also applicable in ICAs. 31 A similar proportion of ICU low-risk monitor patients (94.3%) never received subsequent active therapy, a finding that is similar to the previously reported value (95.6%) 31 and confirms the validity of this method for predicting a low risk (ie, Ͻ 10%) of active therapy in an independent sample of ICU monitor patients.
Low-risk monitor patients with identical diagnoses were frequently admitted to either an ICA or an ICU at the same 32 hospitals. This suggests that physicians use different selection criteria for ICA and ICU admissions among low-risk monitor patients with similar conditions. A greater extent of physiologic abnormality appears to be an important factor in the decision to admit low-risk monitor patients to an ICU rather than an ICA, but other factors that might account for such decisions may not be captured by our data. For example, a surgeon might monitor a patient in the ICU after the patient had undergone an carotid endarterectomy if the obstruction was highly symptomatic or was complicated by significant coronary artery disease, whereas an identical but asymptomatic patient without coronary artery disease might be admitted to an ICA. Although the selection criteria are uncertain, our findings support previous suggestions 3, 31, [42] [43] [44] that physicians can identify low-risk monitor patients who can be treated in an ICA rather than an ICU. Prerequisites for advocating the use of ICAs are patient safety and the ability to improve efficiency and to reduce cost. Our most striking findings were that ICA patients had a significantly higher hospital death rate than ICU low-risk monitor patients (3.1% vs 2.3%, respectively; p Ͻ 0.003) and a longer mean unit length of stay (3.9 vs 2.6 days, respectively; p Ͻ 0.001). This suggests that ICAs may be associated with an excessive death rate and a more prolonged length of stay. Before reaching this conclusion, however, several factors that might explain a higher mortality rate and longer unit length of stay 45, 46 Third, there were differences in prior therapy and in the timing of admission for ICA and ICU low-risk monitor patients. These differences in lead-time could have an important impact on mortality rate and length of stay for ICA patients, particularly those who are transferred from an ICU or from another hospital. As previously shown in ICU populations, an adjustment for each of the above differences is required before mortality rate and length of stay can be compared 36, 47, 48 A preliminary analysis 49 showed that predicted outcomes for ICA patients, which are adjusted for the differences in case mix, patient selection, and lead-time based on their implications for ICU patients, differ from observed values (ie, they are imperfectly calibrated). Thus, APACHE III hospital mortality rate and unit length of stay predictions 50 do not provide accurate benchmarks for assessing these outcomes for ICA patients. Although the same factors are likely to impact outcomes for ICA patients, their implications are probably different than in an ICU population. For this reason, we plan to examine the impact of recalibrating these predictive equations within an ICA population. Our study has several limitations. First, our data cannot be considered to be representative of intermediate care (ie, high-dependency care) in other countries. Studies in the United Kingdom, 9, 51, 52 France, 53, 54 Hong Kong, 55 and New Zealand 56 show that high-dependency units in these countries provide more life support and care for patients with a higher severity of illness and risk of mortality. Second, our data also may not be representative of intermediate care in many US hospitals because of the small number of units studied and due to the nonrandom selection of units for study. Third, we did not collect data about limits on care or about do-not-resuscitate orders, factors that might have a substantial impact on patient survival and triage in ICAs. 36, 57, 58 Fourth, we have no information about the structure or management of ICAs. Factors such as bed availability and triage pressures may have an important impact on unit resource use and patient outcome. 59 In conclusion, this observational sample of ICA patients demonstrates a substantial overlap with those of less severely ill ICU patients. The vast majority of ICA patients are admitted to the unit for monitoring, are at a low risk for receiving subsequent active therapy, and few require transfer to an ICU. Comparisons of unit length of stay and hospital death rate for ICA and ICU low-risk monitor patients, however, will require adjustment for factors that have been shown previously to influence these outcomes. The growing demand for ICU services, coupled with reductions in nurse staffing on floors is likely to increase the need to evaluate the safety and efficiency of ICAs. A description of the clinical features and outcomes for this patient sample represents a first step toward examining patient needs and in developing benchmarks for evaluating resource use and outcomes for ICA patients.
